SCHEMBL15075635

SCHEMBL15075635

Fc1ccc(-c2[nH]c(-c3cccnc3)nc2-c2ccncc2)cc1

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 16/20 0.78
MAPK13 O15264 14/20 0.78
MAPK12 P53778 14/20 0.78
MAPK11 Q15759 14/20 0.78
GCGR P47871 13/20 0.78
ALOX5 P09917 8/20 0.78
CSNK1D P48730 5/20 0.76
PRKD3 O94806 3/20 0.76
MAP4K4 O95819 3/20 0.76
FRK P42685 3/20 0.76
MAPK9 P45984 3/20 0.76
CSNK1A1 P48729 3/20 0.76
GSK3B P49841 3/20 0.76
CLK4 Q9HAZ1 3/20 0.76
PTK6 Q13882 2/20 0.76
PRKD2 Q9BZL6 2/20 0.76
CSNK1E P49674 3/20 0.67
BRAF P15056 2/20 0.67
RAF1 P04049 2/20 0.67
PRKACA P17612 2/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4552316 0.87 MAPK14 (1.00) MAPK14MAPK13MAPK12MAPK11GCGR
SCHEMBL9195042 0.87 MAPK14 (1.00) MAPK14MAPK13MAPK12MAPK11GCGR
SCHEMBL19868925 0.87 MAPK11 (1.00) MAPK14MAPK13MAPK12MAPK11GCGR
SCHEMBL15075603 0.87 MAPK11 (1.00) MAPK14MAPK13MAPK12MAPK11GCGR
SCHEMBL15075705 0.87 MAPK14 (0.70) MAPK14MAPK13MAPK12MAPK11GCGR
SCHEMBL19868948 0.86 MAPK14 (1.00) MAPK14MAPK13MAPK12MAPK11GCGR
SCHEMBL6249453 0.84 MAPK11 (0.56) MAPK14MAPK13MAPK12MAPK11GCGR
SCHEMBL5698659 0.84 ALOX5 (0.75) MAPK14MAPK13MAPK12MAPK11GCGR
SCHEMBL9736817 0.84 MAPK13 (0.71) MAPK14MAPK13MAPK12MAPK11GCGR
SCHEMBL2650702 0.82 MAPK11 (1.00) MAPK14MAPK13MAPK12MAPK11GCGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130165472-A1 HETEROARYLS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2013-06-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130165472-A1 HETEROARYLS AND USES THEREOF PIK3R4, VPS4B, PIK3C2A MAPK14 1023/4885MAPK13 1623/4885MAPK12 2139/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.